PLoS ONE · 2013 · 17 citations · 17 references
Life SciencesImmunologyPharmacologyImmunoregulationInflammationInnate ImmunityCancer ImmunotherapyCytokines In Tumor ImmunityImmune Cell SignalingMedicinal PlantsPlant Immune ResponsesPlant Immune SignalingAnticancer ActivityAntitumor Cytokine ResponsesAntitumor Immune ActivationDifferentiationDose ResponseExtractImmune Response RegulationInnate Antitumor Immunity
Chinese herbal medicines have long been used to treat various illnesses by modulating the human immune response. In this study, we investigate the immuno-modulating effect and antitumor activity of Alocasia Cucullata (AC), a Chinese herb traditionally used to treat infection and cancer. We found that the whole water extract of AC roots could significantly attenuate tumor growth in mouse tumor models. The median survival time of the AC-treated mice was 43 days, 16 days longer than that of the control group. Moreover, the AC-treated mice showed substantially higher induction of key antitumor cytokines, such as IL-2, IFN-γ, and TNF-α, indicating that AC may exert antitumor effect by activating antitumor immunity. To further pinpoint the cellular and molecular mechanism of AC, we studied the dose response of a human monocytic cell line, THP-1, to the whole water extract of AC. Treatment of the AC extract significantly induced THP-1 differentiation into macrophage-like cells and the differentiated THP-1 showed expression of specific macrophage surface markers, such as CD11b and CD14, as well as productions of antitumor cytokines, e.g. IFN-γ and TNF-α. Our data thus point to AC as potentially a new, alternative immuno-modulating herbal remedy for anticancer treatment.
17
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Tobias Sjöblom, Siân Jones, Laura D. Wood et al. · Science · 2006 · 3.2K citations
Patterns of somatic mutation in human cancer genomes
Christopher Greenman, Philip Stephens, Raffaella Smith et al. · Nature · 2007 · 3.1K citations · Full text
Life Sciences, Genetics, Oncology +14
B16 as a Mouse Model for Human Melanoma
Willem W. Overwijk, Nicholas P. Restifo · Current Protocols in Immunology · 2000 · 430 citations · Full text
Life Sciences, Immunology, Oncology +17
T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma
Kevin Chow, Swati Naik, Sunitha Kakarla et al. · Molecular Therapy · 2012 · 248 citations · Full text
Life Sciences, Immunology, Oncology +17